Hexoskin is launching the new ProShirt line for Men and Women with an all-new design to withstand the most active lifestyle and diverse daily living activities. The Hexoskin ProShirt comes with built-in textile ECG & Respiratory sensors and a precise Activity sensor.
Inspired by our most advanced users, the new Hexoskin ProShirt delivers a host of new features with 20 upgrades & improvements compared to our standard Hexoskin Smart Clothing product line.
Today, the Hexoskin ProShirts are used by professional athletes for performance training, police & first responders for longitudinal stress monitoring, and patients in clinical trials living with chronic cardiac & respiratory conditions.
Key Improvements of the Hexoskin ProShirt for Men & Women Include:
All-New Design for Women:
Hexoskin ProShirt Specifications:
Hexoskin has been working for many years with rehabilitation professionals to provide more insights about patients recovering at home. The 34th American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) Annual Meeting in Portland (OR) on September 18-21 will be another great opportunity to connect with the experts who make rehabilitation easier for patients!
AACVRP is home for Cardiovascular and Pulmonary Rehabilitation professionals, where they discuss and promote experiences, challenges, advances and research. We are looking forward to working with a diverse group of heart, respiratory and rehabilitation care specialists to explore new paths to deliver cutting-edge science that keeps patients in the comfort of their home.
The Hexoskin Team will be hosting meetings at the Oregon Convention Center in Portland, Oregon. Our team will be presenting demos of its new clinically validated collection of Smart Garments for remote patient monitoring along with the Hexoskin Connected Health Platform, already used for rehabilitation and health research in cardiology, pulmonology, psychiatry, rare diseases and many other health conditions.
Keep patients at home. Make patients healthier. That's what professionals working in cardiac rehabilitation and pulmonary rehabilitation do. All year long. Hexoskin helps them get data about their patients and answer these questions:
This helps rehabilitation professionals personalize their approach and provide services to patients remotely. Almost every patient should be in a cardiac rehab program after a heart attack. Currently, in the US and Canada, less than 20% of eligible patients participate in a cardiac rehab program. For pulmonary rehab (COPD patients), it's less than 4%! This low participation rate is costing Medicare billions of dollars in additional hospitalization fees. Most importantly, millions of patients are not getting the care that would keep them out of the hospital. We need to make cardiac and pulmonary rehabilitation more accessible. That's why we'll be in Portland this week.
Founded in 2006 in Montreal, Hexoskin (Carré Technologies Inc.) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.
On September 12th this week, Hexoskin's Co-founder & CTO Jean-François Roy will discuss sensors, data, and AI in medicine at the Intelligent Health AI conference in Basel, Switzerland.
Hexoskin has been chosen among only 5 companies in the world to present at the Showcase event at the conference sponsored by Novartis. Hexoskin's Chief Technology Officer Jean-François Roy will present new opportunities for healthcare and pharmaceutical organizations to uncover new insights from the data they have collected from clinical trials.
Artificial Intelligence and Machine Learning have the potential to transform drug development and reduce the time to market of much-needed therapies in various therapeutic areas, including rare diseases, and find new cures for millions of patients.
The Hexoskin end-to-end data platform is secure and platform agnostic. Hexoskin's clients have access to cost-effective tools to manage clinical studies, collect rich health data, and build unique databases and datasets for machine learning & AI projects.
Hexoskin has a dedicated group of AI & biomedical researchers with years of experience in preparing and analyzing health data, and in the development of machine learning algorithms with health data. Its research team collects new vital signs data and use external datasets to answer novel research questions.
Founded in 2006 in Montreal, Hexoskin is the leader in non-invasive sensors, smart clothing, software, data science & AI services. Hexoskin launched in 2013 the first washable smart shirts that capture cardiac, respiratory, and activity body metrics. The Hexoskin platform is an end-to-end software system to monitor and analyse users' general health, vital signs, sleep, and activity, using built-in sensors embedded in smart garments made in Canada.
The Hexoskin smart clothing and Hexoskin Connected Health Platform has been used to collect data for over 70 scientific publications in the fields of cardiology, respiratory, behavioural & physiological psychology, sleep patterns, circadian rhythms, effects of aging on physical performance, and AI-Machine Learning. The company provides custom solutions, R&D project management, and services to international clients including pharmaceuticals, research centers, government agencies, and healthcare providers.
Hexoskin is attending the DSEI Defense & Security convention on September 10-13, 2019 in London.
Our team will be hosting meetings in London with Defense & Security stakeholders to showcase our solutions and expertise for monitoring soldiers & first responders vital signs, health status, stress, and performance in training or in the field.
DSEI is the world-leading event that connects governments, national armed forces, industry thought leaders in the global defense, first response, & security supply. Where to showcase the latest equipment and systems available and discover our latest capabilities across the Defense & Security domains.
The Hexoskin Team will be introducing the next evolution of smart clothing for defense, first responders, and stress monitoring: the Hexoskin ProShirt.
Pre-orders are available now and will start shipping on September 10, 2019.
Hexoskin and Halo Health are announcing today a collaboration to solve key challenges in running clinical trials. Combining Hexoskin and Halo Health's technology will offer greater operational efficiency for virtual clinical trials and home monitoring, and offer tools to increase patient engagement.
These new tools will reduce the cost of collecting vital signs data for clinical trials, and will allow patients to participate in medical research from the comfort of their home.
Hexoskin smart garments and its Connected Health Platform are compatible with Halo Health solutions. The two companies will mutually promote their offering to pharmaceutical sponsors to support clinical development.
Halo Health is enabling patient-centric trials to reduce patient and site burden. Its Smart Clinical Trials solution is a digital health platform that provides Remote Patient Monitoring, Patient Engagement, and Workflow Automation. The solution includes an integrated ecosystem of clinical grade sensors and wearables to enable hybrid & virtual trials for various therapeutic areas including cardiology, respiratory and endocrinology.
Pierre-Alexandre Fournier - Chief Executive Officer at Hexoskin: “Medicine's progress depends on being able to better observe patients' outcomes. Anything we can do to lower the cost of data helps accelerate clinical development. This is something that Pharma and Biotech companies need to innovate, but most importantly this is something that we need to do to improve treatments for patients and find new cures for diseases that affect millions of people and their families.” says Pierre-Alexandre Fournier, Chief Executive Officer at Hexoskin. “Combining Halo Health's software with Hexoskin sensors and algorithms reduces the cost of collecting data in clinical trials, with greater flexibility & patient centricity.”
Hexoskin is a pioneer and leader in non-invasive vital signs sensors and remote patient monitoring solutions. Hexoskin Smart Clothing for Men, Women, and Children are clinically validated and its Connected Health Platform is used for health research in cardiology, pulmonology, psychiatry, rare diseases and many other health conditions.
Contact Hexoskin to learn more.
Earlier this month, European Space Agency astronaut Luca Parmitano conducted validation tests on-orbit and wore the Astroskin garment and headband connected to the data unit for his first 72-hour monitoring experience.
Luca Parmitano also conducted maintenance operations for the Astroskin / Bio-Monitor that was deployed on the ISS orbiting lab, last December by Canadian Astronaut David Saint-Jacques.
Although the ISS is equipped with health and life sciences research tools, the existing instrumentation for continuous and simultaneous recording of several physiological parameters was lacking. To address this issue, the Canadian Space Agency's Bio-Monitor Commissioning activity uses the Astroskin / Bio-Monitor system; a complete vital signs monitoring platform coupled with a wearable garment capable of monitoring relevant physiological parameters in a non-invasive and non-interfering way during a normal day in space.
The physiological parameters which can be monitored consist of blood pressure, peripheral blood oxygen saturation, 3-lead ECG, respiration, skin temperature, and activity, will help push further our understanding of Vascular aging and Human Physiology in space.
Venturing into the environment of space, microgravity can have negative effects on the human body. When astronauts return to Earth, their carotid arteries, which carry blood to the head and neck, appear to have aged 20 to 30 years. Artery walls become stiffer and thicker in space, the same as when people grow older on Earth.
“You can take extremely healthy, fit astronauts and put them in an environment that restricts their ability to do daily exercise, and they run the risk of developing insulin resistance that on Earth could lead to Type II diabetes,” said principal investigator Richard L. Hughson of Schlegel-University of Waterloo in Ontario
Now operational the Astroskin Bio-Monitor system is available for the next five years to conduct Health research in Space for all participating countries to the International Space Station.
Sometimes you wear the experiment: the Bio-Monitor smart shirt system measures vital signs like temperature, heart rate, respiration and movement, and transmits the data to a tablet application. #MissionBeyond @csa_asc pic.twitter.com/2h6lmRUyHH— Luca Parmitano (@astro_luca) 19 août 2019
Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. The Astroskin demonstrates once again Hexoskin’s leadership in providing the industry leading sensors, software, and AI to push further our understanding of human physiology on earth and in space.
Montreal, Canada, August 22, 2019 - The CIHR (Canadian Institutes of Health Research) organized a press conference at CHU Sainte-Justine, Mother and Child University Hospital Center today to announce the funding of a five-year project to collect biological and vital signs data from patients suffering from Myalgic Encephalomyelitis (ME), also known as Chronic Fatigue Syndrome (CFS), to improve medical knowledge of the disease. Canadian Minister of Health, the Honourable Ginette Petitpas Taylor, was at the event to make the announcement with Dr. Alain Moreau, Scientific Director of the Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases.
In Canada, over half a million Canadians suffer from ME. According to the CDC (Center for Disease Control and Prevention), in the United States, 836,000 to 2.5 million Americans suffer from ME, but most of them have not been diagnosed. There is currently no biological diagnostic test for ME. The disease is diagnosed based on symptoms and by ruling out other conditions that could be causing the symptoms. The CHIR funded project will build the largest long-term cardiopulmonary and activity database in the world for patients with ME.
Hexoskin, a Montreal-based leader in smart clothing, health software, and AI services will provide its health monitoring solutions to support building the database. Pierre-Alexandre Fournier, CEO of Hexoskin, is pleased by today’s announcement: ‘’We believe this project will help us understand how to better take care of patients presenting symptoms of ME. Recent data shows that the prevalence of this disease is higher than previously estimated and has an enormous impact on Canadians living with ME and our society. Data collected in this project will impact millions of lives’’.
Dr. Alain Moreau will be the Principal Investigator with the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis - ICANCME - Research Network: “Myalgic Encephalomyelitis (ME) is possibly the last medical enigma of the 21st century. Our scientific partnership with Hexoskin will be instrumental to address the complexity of ME given its clinical heterogeneity and phenotypic variability overtime. The Hexoskin wearable technologies will allow researchers and clinicians to investigate people severely affected by ME (housebound or bedridden), which is rarely done due to their limited capacity to participate in clinical studies.”
Founded in 2006 in Montreal, Hexoskin is the leader in non-invasive sensors, smart clothing, software, data science & AI services. Hexoskin launched in 2013 the first washable smart shirts that capture cardiac, respiratory, and activity body metrics. Hexoskin is an end-to-end system to monitor the user’s general health, vital signs, sleep, and activity, using built-in sensors embedded in Smart Garments made in Canada. The system can be used for a wide range of research domains including cardiology, respiratory, behavioural and physiological psychology, biofeedback, sleep patterns, circadian rhythms, effects of aging on physical performance, human energy expenditure, and physical conditioning.
The Hexoskin smart clothing and solutions were validated in over 70 scientific publications in the fields of cardiology, respiratory, behavioural and physiological psychology, sleep patterns, circadian rhythms, effects of aging on physical performance, and AI-Machine Learning. The company provides custom solutions, R&D project management, and services to international clients in defence, aerospace, security, police and first responders, pharmaceuticals, academics, and healthcare.
Hexoskin is also known for collaborating with the Canadian Space Agency to provide its advanced health technologies Astroskin (Bio-Monitor) to monitor the vital signs of the Canadian Astronaut David Saint-Jacques and future astronauts visiting in the International Space Station for the next five years. The company launched in 2018 the Astroskin platform for research and public/private projects on Earth.
Our community of Developers asked for it and we are now making the Hexoskin SDK for Android widely available.
The new SDK (Software Development Kit) is a compiled library that provides access to the Hexoskin raw signals and data quality channels in real-time to develop groundbreaking apps on Android smartphones and tablets.
Here's an overview of the Hexoskin's SDK License and Integration Support provided:
Roxanne Vogel, Mountaineer and Nutrition & Performance Research Manager at Gu Energy Labs, became the first person to complete a lightning ascent of Mount Everest. On a normal climb, the journey would take nearly two months, but Vogel completed the round trip in just 14 days.
The Hexoskin team wants to congrats Roxanne for completing this amazing challenge and reaching the top of the world!
Roxanne turned the experience into a science project to study the effects of a rapid ascent on the human body. For this journey, the Astroskin Shirt presented itself as an important measurement tool to study the Montaineer vital signs during the ascent. «It was a non-invasive method to collect novel data above 7000 m continuously and in real-time so that I could not only monitor my physiology for safety reasons but also gather information about how the human body adapts to high altitude hypoxia in such a short amount of time. This is the first time the world will see continuous data of this nature for the variables Astroskin measures! I needed something I could put on, press start, and forget about that didn’t take up much space or weight to carry, and Astroskin was the perfect solution.
The Astroskin Shirt is comfortable to wear and the set up is very user-friendly. I put it on and basically forgot it was there, except when I had to change batteries. It made my life as a scientist on the mountain so much easier than if I were to attempt to collect similar variables at distinct data points, which would only provide a “snapshot” of the data, not a complete picture. Overall, it was a great experience using the Astroskin», said Roxanne Vogel, Mountaineer and Nutrition & Performance Research Manager at Gu Energy Labs
Roxanne left Berkeley on May 10 for the 14 days Mount Everest Lightning Ascent and complete her sixth summit climb out of the world’s seven highest mountains. Vogel spent four months training with coaches and three months training for the changes in altitude.
Roxanne Vogel reached the summit on May 22 at 11:45 a.m and arrived back in the San Francisco at 11 p.m. Friday. Her next adventure is in Antarctica, where she will endeavor to complete her seven-summit goal by the end of the year.
«My friend and hero Lydia Bradey and I summited Mount Everest (8848 meters/29,029 ft), the first climbing members to reach it from the Tibet side this season, just as the rope-fixers finished putting up the final 500 vertical feet of lines. They hugged and high-fived us as they descended, leaving us alone with our two Sherpas, Mingma Tshering and Pasang Tendi, on the summit, an incredible and almost non-existent experience.
We climbed from Camp 2 at 7700 meters, departing late by Everest standards at 1:45 AM, to give the rope fixers time to finish their work. No one else climbed from the north side that day. We were so fortunate to have the mountain all to ourselves. Hard to believe, still processing.»
— Pierre A Fournier (@pafournier) 23 mai 2019
Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. The Astroskin demonstrates once again Hexoskin’s leadership in providing the industry leading sensors, software, and AI to push further our understanding of human physiology on earth and in space. Contact our team to order Astroskin
In 2013, Hexoskin launched a unique solution that revolutionized how we monitor cardiac, respiratory, activity, and sleep data with sensors embedded in a comfortable and machine washable smart garment.
Hexoskin was the first smart clothing compatible with the iPhone. We also opened our API to allow developers and researchers to leverage the value provided by our solutions.
Today, the Hexoskin Connected Health Platform is an end-to-end solution that offers leading-edge sensors, software, and data science tools. It is used by researchers, public and private organizations, athletes, and users who value precise, accessible, and useful health data.
The Hexoskin Connected Health Platform is currently used for Machine Learning and Artificial Intelligence research and projects that will change how patients receive care. Here is an overview of the Hexoskin Connected Health Platform.
The Hexoskin Connected Platform is a powerful, yet flexible option that can fit any project sizes. Try it today ! Visit our Health Research Page to learn more about the research and validation conducted with Hexoskin. You can always contact us if you have any questions or need advises on how to leverage the Hexoskin Connected Health Platform for your research or project.
Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.